• Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
  • Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
  • Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
  • Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
  • Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
  • Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues

Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues

CAS No.: 330936-69-1
Formula: C119h204n34o32s2
EINECS: 330936-69-1
Type: API
Appearance: Powder
Quality: Pharma Grade
Samples:
US$ 15/vial 1 vial(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2023

Suppliers with verified business licenses

Zhejiang, China
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
to see all verified strength labels (12)
  • Overview
  • Product Description
  • Detailed Photos
  • Company Profile
  • Certifications
  • Customers feedback
Overview

Basic Info.

Model NO.
330936-69-1
Colour
White
Peptide Purity
>99.0% HPLC
Molecular Mass
2195.44
Bacterial Endotoxins
< 10 EU/Mg
Total Aerobic Microbial Count
< 10 Cfu/G
Total Combined Yeasts and Moulds Count
< 10 Cfu/G
Storage Condition
2c - 8c, Well-Closed Containers
Transport Package
Vials/Tray/Tube
Specification
10mg 20mg
Trademark
OEM
Origin
China
Production Capacity
1-5kgs Per Month

Product Description

Product Description

Humanin (HN) is a mitochondrial-derived peptide with cytoprotective effect in many tissues. Administration of HN analogs has been proposed as therapeutic approach for degenerative diseases. Although HN has been shown to protect normal tissues from chemotherapy, its role in tumor pathogenesis is poorly understood. Here, we evaluated the effect of HN on the progression of experimental triple negative breast cancer (TNBC). The meta-analysis of transcriptomic data from The Cancer Genome Atlas indicated that HN and its receptors are expressed in breast cancer specimens. By immunohistochemistry we observed up-regulation of HN in TNBC biopsies when compared to mammary gland sections from healthy donors. Addition of exogenous HN protected TNBC cells from apoptotic stimuli whereas shRNA-mediated HN silencing reduced their viability and enhanced their chemo-sensitivity. Systemic administration of HN in TNBC-bearing mice reduced tumor apoptotic rate, impaired the antitumor and anti-metastatic effect of chemotherapy and stimulated tumor progression, accelerating tumor growth and development of spontaneous lung metastases. These findings suggest that HN may exert pro-tumoral effects and thus, caution should be taken when using exogenous HN to treat degenerative diseases. In addition, our study suggests that HN blockade could constitute a therapeutic strategy to improve the efficacy of chemotherapy in breast cancer.

 
Items Specifications
Business Type We are a manufacturer of GMP peptide and provide OEM service. The lid also can be customized
Filling amount The filling amount is 2-5mg extra per bottle.
Purity The purity is above 99%
Price Competitive price
Delivery time The delivery time is stable and short. If you pay before 12 a.m,the goods can be shipped on the same day.
Shipping risk If the package was lost we will resend the goods to you,so you won't suffer a loss if you buy it.
Detailed Photos


Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Company Profile

Zhaobo Bio acquired early mastery of development and manufacturing of peptides, the short chain amino acids linked by peptide bonds that have enabled new generations of small molecule drugs that closely mimic the body's natural pathways.
Now Zhaobo Bio possesses first-class capabilities to manufacture peptides at industrial scale and in full compliance with the strictest Good Manufacturing Practice (GMP) standards.


Upstream peptide synthesis
Zhaobo Bio production plants are endowed with state-of-the-art equipment for solvent supply, peptide synthesis, purification and isolation of active ingredients and intermediates. All equipment and containment is GMP qualified and cleaning validated. Overlapping capacities and sizes of different equipment trains facilitate a smooth scale-up for increases in demand within the product life cycle. 

Downstream purification and isolation of peptides
Zhaobo Bio is committed to the systematic expansion and modernization of its purification equipment in order to ensure the efficient production of ever-increasing amounts of bulk peptide pharmaceuticals.
It uses sophisticated methods for large scale purification campaigns such as preparative high performance liquid chromatography (HPLC), ion exchange (IEX), size-exclusion chromatography (SEC), and ultra-filtration (UF/TFF). The equipment in place permits highly efficient or even continuous manufacturing of extremely pure products up to multi-kg quantities per lot.
For preparative HPLC, dynamic axial compression (DAC) stainless steel columns of up to 60 cm diameter both in batch and continuous mode are packed with the appropriate high performance silica separation phase. For low-pressure chromatography columns up to 80 cm diameter are available. Solvent delivery is ensured from eluent tank farms and containers.
The control of microbiological contamination is a prerequisite for API manufacturing. Class D (ISO 8) and C (ISO 7) clean rooms are supplied via HEPA-filtered, temperature and humidity controlled air, down-flow booths are used for minimizing microbial contamination and protecting operators. Highly active pharmaceutical ingredients are handled in integrated safety workbenches or flexible isolators reaching OEB level 4 (1-10 µg/m3).
Predefined physicochemical properties of the API can only be achieved by a carefully controlled isolation process. Besides precipitation and crystallization, lyophilization of intermediates and final API is a standard unit operation.  LaixingPharma have multiple lyophilizers in different sizes (up to 300 liters) located in clean rooms.


Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues

Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Certifications

 

Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many TissuesFactory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues
Customers feedback

 

Factory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many TissuesFactory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many TissuesFactory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many TissuesFactory Wholse Mitochondrial-Derived Peptide Humanin with Cytoprotective Effect in Many Tissues

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2023

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
70000000 RMB
Management System Certification
ISO 9001, ISO 14001, ISO 20000, GMP, HACCP, FSC